Goldman Sachs Maintains Neutral on Twist Bioscience, Lowers Price Target to $43
Goldman Sachs analyst Matthew Sykes maintains Twist Bioscience (NASDAQ:TWST) with a Neutral and lowers the price target from $50 to $43.
Why Twist Bioscience Stock Is Plunging Today
Shares of Twist Bioscience Corp (NASDAQ:TWST) fell after the firm issued fiscal second-quarter revenue guidance that fell below the consensus Wall Street…
Twist Bioscience And Astellas Enter Into Multitarget Antibody Discovery Research Collaboration
Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a research collaboration
Scotiabank Initiates Coverage On Twist Bioscience with Sector Outperform Rating, Announces Price Target of $33
Scotiabank analyst Sung Ji Nam initiates coverage on Twist Bioscience (NASDAQ:TWST) with a Sector Outperform rating and announces Price Target of $33.
Stocks That Hit 52-Week Lows On Thursday
Thursday's session saw 329 companies set new 52-week lows.
Wall Street’s Analyst Just Said On Dell Technologies; Here Are Other Picks For Last Week From Top Analysts
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors confused about which analyst's opinion to trust.
Baird Maintains Outperform on Twist Bioscience, Lowers Price Target to $33
Baird analyst Catherine Schulte maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and lowers the price target from $56 to $33.
Barclays Maintains Overweight on Twist Bioscience, Lowers Price Target to $43
Barclays analyst Luke Sergott maintains Twist Bioscience (NASDAQ:TWST) with a Overweight and lowers the price target from $45 to $43.
ConocoPhillips To Plunge Over 11%? Plus This Analyst Slashes PT On LiveOne By 25%
Societe Generale boosted the price target on ConocoPhillips (NYSE: COP) from $106 to $114. ConocoPhillips shares fell 2% to close at $128.59 on Friday.